“The Capture of Academia: How Universities Shape Power, Silence Dissent, and Influence Society“ trialsitenews.com/a/the-capt…

Moderna’s melanoma breakthrough is real. So is its valuation problem: ~$83 BILLION for a company losing money and trading at ~37× sales. Investors are paying today for cancer victories still unproven—and patients still need affordable access. trialsitenews.com/a/modernas…

Sweden chose a protein-based COVID vaccine for 27–28. Did it ban mRNA vaccines over safety? The evidence doesn’t say that. The harder question: Why did Sweden choose Nuvaxovid—and what happens for younger patients? A public contract deserves public answers trialsitenews.com/a/sweden-c…

Can diet shape teen mental health? A study of 6,537 Australian adolescents linked higher fruit intake to fewer depression symptoms and sugary drinks to more symptoms. But association isn’t causation. The unanswered question: Did diet come first? trialsitenews.com/a/more-fru…

2.3 MILLION COVID vaccine adverse-event reports. 612 statistical safety signals. Nearly 30,000 reports involving death. An independent EU watchdog is demanding answers. These are NOT confirmed vaccine injuries—but they warrant scrutiny. trialsitenews.com/a/eu-vigil…

China is taking rare earths into a new frontier: MEDICINE. Cancer treatment with Lutetium-177. Advanced tumor imaging. Nanoparticles. Bone regeneration. 23 research presentations reveal China's growing biomedical ambitions. trialsitenews.com/a/chinas-r…

Are ultraprocessed foods changing our children's brains? A new JAMA study found that kids who ate more ultra-processed foods showed stronger brain responses to food images and gained more body fat over time. But did the food cause these changes? Not proven trialsitenews.com/a/are-ultr…

Hundreds of millions vaccinated. 5y later, are critical mRNA safety questions still unanswered? A new peer-reviewed review by 16 researchers raises concerns about heart inflammation, lipid nanoparticles, unintended proteins, and manufacturing controls. trialsitenews.com/a/hundreds…

A flu shot. Paralysis. 12 years fighting the government. South Korea’s Supreme Court ruled that a vaccine injury payout cannot automatically end medical reimbursement. The patient died before justice arrived. trialsitenews.com/a/new-scie…

Are doctors being treated as sales targets instead of medical professionals? A leaked Novo database reportedly ranked thousands of physicians by commercial value and prescribing loyalty. Who controls this data? trialsitenews.com/a/novo-nor…

The GLP-1 weight-loss boom has a safety question Big Pharma cannot ignore. A new peer-reviewed review of tirzepatide (Mounjaro/Zepbound) identifies pancreatitis and gallbladder complications across clinical trials and real-world reports. trialsitenews.com/a/new-tirz…

Moderna's cancer vaccine: breakthrough or billion-dollar affordability problem? Merck/Moderna tout a 42% lower risk of melanoma recurrence or death. Impressive. But the absolute benefit at 2 years? 12.2 percentage points. trialsitenews.com/a/modernas…

What if mRNA vaccines don't need lipid nanoparticles after all? Japanese researchers achieved a 323-fold reduction in SARS-CoV-2 viral RNA in mice using naked mRNA—without LNPs—and observed less inflammation than with an experimental LNP formulation. trialsitenews.com/a/scientis…

Moderna’s pediatric mRNA RSV vaccine raises serious questions. An earlier infant trial found severe/hospitalized RSV illness in 5/40 vaccinated vs. 1/20 placebo recipients. A new trial shows strong antibodies—but still cannot resolve the safety concern. trialsitenews.com/a/modernas…

DID THE NEW YORK TIMES CROSS THE LINE? Did the NYT turn one NIH board chairman’s objections into a misleading narrative of unanimous opposition to RFK Jr.’s vaccine injury clinic? New accounts challenge the story. Potential conflicts raise more questions. trialsitenews.com/a/did-the-…

Could a $10 bottle of Vitamin C help patients at risk of leukemia live longer? A randomized trial found 11 deaths among 55 vitamin C patients vs. 24 among 54 on placebo. But the primary endpoint FAILED. Breakthrough or statistical mirage? trialsitenews.com/a/vitamin-…

FDA Approves Hepatitis B Breakthrough—but at What Risk? GSK’s Hibsago achieved a functional cure in 19% of patients, but serious adverse events occurred in 7% vs. 4% on placebo. trialsitenews.com/a/fda-appr…

America’s teen health crisis: A new CDC study finds just 16% of high school students meet both exercise guidelines, while only 27% eat breakfast daily. Even more troubling? School physical education is declining despite rising sports participation. trialsitenews.com/a/cdc-stud…

A new NIH-funded study warns that delaying the hepatitis B birth dose could increase childhood infections by 83%. But that’s 212 additional modeled cases among 3.6 million newborns—not observed infections. trialsitenews.com/a/hepatiti…

Could a monoclonal antibody help patients suffering from Long COVID or COVID-19 vaccine injury? Invivyd and Mount Sinai-affiliated researchers launch FLINTLOCK, a 130-patient Phase 2 trial testing VYD2311. trialsitenews.com/a/invivyd-…

NIH is finally taking vaccine injury seriously—but will patients get answers or just another federal research program? A new center promises to investigate post-vaccination illness and Long COVID. trialsitenews.com/a/nih-open…